1. Home
  2. MNKD vs BHE Comparison

MNKD vs BHE Comparison

Compare MNKD & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • BHE
  • Stock Information
  • Founded
  • MNKD 1991
  • BHE 1979
  • Country
  • MNKD United States
  • BHE United States
  • Employees
  • MNKD N/A
  • BHE N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • BHE Electrical Products
  • Sector
  • MNKD Health Care
  • BHE Technology
  • Exchange
  • MNKD Nasdaq
  • BHE Nasdaq
  • Market Cap
  • MNKD 1.7B
  • BHE 1.4B
  • IPO Year
  • MNKD 2004
  • BHE 1990
  • Fundamental
  • Price
  • MNKD $5.33
  • BHE $42.29
  • Analyst Decision
  • MNKD Strong Buy
  • BHE Strong Buy
  • Analyst Count
  • MNKD 5
  • BHE 2
  • Target Price
  • MNKD $10.80
  • BHE $46.50
  • AVG Volume (30 Days)
  • MNKD 4.4M
  • BHE 213.5K
  • Earning Date
  • MNKD 11-05-2025
  • BHE 11-04-2025
  • Dividend Yield
  • MNKD N/A
  • BHE 1.61%
  • EPS Growth
  • MNKD 149.32
  • BHE N/A
  • EPS
  • MNKD 0.11
  • BHE 1.05
  • Revenue
  • MNKD $301,736,000.00
  • BHE $2,588,733,000.00
  • Revenue This Year
  • MNKD $14.78
  • BHE $0.03
  • Revenue Next Year
  • MNKD $19.36
  • BHE $5.83
  • P/E Ratio
  • MNKD $50.09
  • BHE $40.41
  • Revenue Growth
  • MNKD 21.48
  • BHE N/A
  • 52 Week Low
  • MNKD $3.38
  • BHE $30.73
  • 52 Week High
  • MNKD $7.63
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 49.48
  • BHE 61.05
  • Support Level
  • MNKD $5.28
  • BHE $41.88
  • Resistance Level
  • MNKD $5.62
  • BHE $43.12
  • Average True Range (ATR)
  • MNKD 0.24
  • BHE 1.27
  • MACD
  • MNKD -0.02
  • BHE 0.43
  • Stochastic Oscillator
  • MNKD 58.80
  • BHE 88.39

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: